UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 41

Sortiert nach

Increase in the oxidized/total coenzyme Q-10 ratio in the cerebrospinal fluid of Alzheimer's disease patients

Dementia and geriatric cognitive disorders, 2009-01, Vol.28 (5), p.449

2009

Volltextzugriff (PDF)

Levels of reduced and oxidized coenzymeQ-10 and 8-hydroxy-2′-deoxyguanosine in the cerebrospinal fluid of patients with living Parkinson's disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process

Neuroscience letters, 2010-01, Vol.469 (1), p.159-163

2010

Volltextzugriff (PDF)

A Remarkable Increase in Total Homocysteine Concentrations in the CSF of Migraine Patients With Aura

Headache, 2010-11, Vol.50 (10), p.1561-1569

2010

Volltextzugriff (PDF)

Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2′-deoxyguanosine in the CSF of patients with Alzheimer’s disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process

Journal of neurology, 2010-03, Vol.257 (3), p.399-404

2010

Volltextzugriff (PDF)

Increase of total homocysteine concentration in cerebrospinal fluid in patients with Alzheimer's disease and Parkinson's disease

Life sciences (1973), 2005-08, Vol.77 (15), p.1836-1843

2005

Volltextzugriff (PDF)

Randomized controlled trial of KW-6356 monotherapy in patients with early untreated Parkinson's disease

Parkinsonism & related disorders, 2023-12, Vol.117, p.105907-105907, Article 105907

2023

Volltextzugriff (PDF)

L-Dopa therapy increases homocysteine concentration in cerebrospinal fluid from patients with Parkinson’s disease

Journal of clinical neuroscience, 2010-06, Vol.17 (6), p.717-721

2010

Volltextzugriff (PDF)

Remarkable increase in 3-nitrotyrosine in the cerebrospinal fluid in patients with lacunar stroke

Brain research, 2009-12, Vol.1305, p.132-136

2009

Volltextzugriff (PDF)

Homocysteine May Contribute to Pathogenesis of RNA Damage in Brains with Alzheimer’s Disease

Neuro-degenerative diseases, 2009-01, Vol.6 (5-6), p.252-257

2009

Volltextzugriff (PDF)

Remarkable increase in the concentration of 8-hydroxyguanosine in cerebrospinal fluid from patients with Alzheimer's disease

Journal of neuroscience research, 2002-11, Vol.70 (3), p.447-450

2002

Volltextzugriff (PDF)

Decrease in Asymmetrical Dimethylarginine, an Endogenous Nitric Oxide Synthase Inhibitor, in Cerebrospinal Fluid during Elderly Aging and in Patients with Sporadic Form of Amyotrophic Lateral Sclerosis

Neuro-Signals, 2010-01, Vol.18 (1), p.43-48

2010

Volltextzugriff (PDF)

Alteration of 8-hydroxyguanosine concentrations in the cerebrospinal fluid and serum from patients with Parkinson's disease

Neuroscience letters, 2003-01, Vol.336 (2), p.105-108

2003

Volltextzugriff (PDF)

L-Dopa therapy increases homocysteine concentration in cerebrospinal fluid from patients with Parkinson' s disease

Journal of clinical neuroscience, 2010-06, Vol.17 (6), p.717-721

2010

Volltextzugriff (PDF)

Remarkable increase in cerebrospinal fluid 3-nitrotyrosine in patients with sporadic amyotrophic lateral sclerosis

Annals of neurology, 1999-07, Vol.46 (1), p.129-131

1999

Volltextzugriff (PDF)

Alterations of 3-nitrotyrosine concentration in the cerebrospinal fluid during aging and in patients with Alzheimer's disease

Neuroscience letters, 1999-07, Vol.269 (1), p.52-54

1999

Volltextzugriff (PDF)

Increase of oxidized/total coenzyme Q-10 ratio in cerebrospinal fluid in patients with Parkinson’s disease

Journal of clinical neuroscience, 2007-04, Vol.14 (4), p.340-343

2007

Volltextzugriff (PDF)

Reduction in asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in the cerebrospinal fluid during aging and in patients with Alzheimer's disease

Neuroscience letters, 2001-10, Vol.312 (3), p.177-179

2001

Volltextzugriff (PDF)

Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2'-deoxyguanosine in the cerebrospinal fluid of patients with living Parkinson's disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process

Neuroscience letters, 2010-01, Vol.469 (1), p.159-163

2010

Volltextzugriff (PDF)

Increase in oxidized NO products and reduction in oxidized glutathione in cerebrospinal fluid from patients with sporadic form of amyotrophic lateral sclerosis

Neuroscience letters, 1999-02, Vol.260 (3), p.204-206

1999

Volltextzugriff (PDF)

Identification of odontogenic ameloblast associated as a novel target gene of the Wnt/β‐catenin signaling pathway

Cancer science, 2023-03, Vol.114 (3), p.948-960

2023

Volltextzugriff (PDF)

Near infrared photoimmunotherapy targeting DLL3 for small cell lung cancer

EBioMedicine, 2020-02, Vol.52, p.102632, Article 102632

2020

Volltextzugriff (PDF)

HER2 targeting near‐infrared photoimmunotherapy for a CDDP‐resistant small‐cell lung cancer

Cancer medicine (Malden, MA), 2021-12, Vol.10 (24), p.8808-8819

2021

Volltextzugriff (PDF)

An EST-SSR Linkage Map of Raphanus sativus and Comparative Genomics of the Brassicaceae

DNA research, 2011-08, Vol.18 (4), p.221-232

2011

Volltextzugriff (PDF)

EMPRESS. XII. Statistics on the Dynamics and Gas Mass Fraction of Extremely Metal-poor Galaxies

The Astrophysical journal, 2024-01, Vol.961 (1), p.49

2024

Volltextzugriff (PDF)

Entrectinib‐induced syndrome of inappropriate antidiuretic hormone secretion in a patient with ROS1 ‐rearranged non‐small cell lung cancer

Respirology case reports, 2023-10, Vol.11 (10), p.n/a

2023

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(40)
Berichte
(1)

Sprache

Englisch
(41)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(34)
Life Sciences & Biomedicine
(29)
Humans
(23)
Female
(19)
Male
(17)
Neurosciences & Neurology
(16)
Aged
(15)
Biological And Medical Sciences
(15)
Middle Aged
(15)
Cerebrospinal Fluid
(14)
Neurosciences
(13)
Neurology
(12)
Medical Sciences
(11)
Clinical Neurology
(8)
Alzheimer Disease - Cerebrospinal Fluid
(7)
Alzheimer's Disease
(7)
Fundamental And Applied Biological Sciences. Psychology
(6)
Parkinson's Disease
(6)
Tumors
(6)
Oxidative Stress
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Increase in the oxidized/total coenzyme Q-10 ratio in the cerebrospinal fluid of Alzheimer's disease patients

Levels of reduced and oxidized coenzymeQ-10 and 8-hydroxy-2′-deoxyguanosine in the cerebrospinal fluid of patients with living Parkinson's disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process

A Remarkable Increase in Total Homocysteine Concentrations in the CSF of Migraine Patients With Aura

Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2′-deoxyguanosine in the CSF of patients with Alzheimer’s disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process

Increase of total homocysteine concentration in cerebrospinal fluid in patients with Alzheimer's disease and Parkinson's disease

Randomized controlled trial of KW-6356 monotherapy in patients with early untreated Parkinson's disease

L-Dopa therapy increases homocysteine concentration in cerebrospinal fluid from patients with Parkinson’s disease

Remarkable increase in 3-nitrotyrosine in the cerebrospinal fluid in patients with lacunar stroke

Homocysteine May Contribute to Pathogenesis of RNA Damage in Brains with Alzheimer’s Disease

Remarkable increase in the concentration of 8-hydroxyguanosine in cerebrospinal fluid from patients with Alzheimer's disease

Decrease in Asymmetrical Dimethylarginine, an Endogenous Nitric Oxide Synthase Inhibitor, in Cerebrospinal Fluid during Elderly Aging and in Patients with Sporadic Form of Amyotrophic Lateral Sclerosis

Alteration of 8-hydroxyguanosine concentrations in the cerebrospinal fluid and serum from patients with Parkinson's disease

L-Dopa therapy increases homocysteine concentration in cerebrospinal fluid from patients with Parkinson' s disease

Remarkable increase in cerebrospinal fluid 3-nitrotyrosine in patients with sporadic amyotrophic lateral sclerosis

Alterations of 3-nitrotyrosine concentration in the cerebrospinal fluid during aging and in patients with Alzheimer's disease

Increase of oxidized/total coenzyme Q-10 ratio in cerebrospinal fluid in patients with Parkinson’s disease

Reduction in asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in the cerebrospinal fluid during aging and in patients with Alzheimer's disease

Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2'-deoxyguanosine in the cerebrospinal fluid of patients with living Parkinson's disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process

Increase in oxidized NO products and reduction in oxidized glutathione in cerebrospinal fluid from patients with sporadic form of amyotrophic lateral sclerosis

Identification of odontogenic ameloblast associated as a novel target gene of the Wnt/β‐catenin signaling pathway

Near infrared photoimmunotherapy targeting DLL3 for small cell lung cancer

HER2 targeting near‐infrared photoimmunotherapy for a CDDP‐resistant small‐cell lung cancer

An EST-SSR Linkage Map of Raphanus sativus and Comparative Genomics of the Brassicaceae

EMPRESS. XII. Statistics on the Dynamics and Gas Mass Fraction of Extremely Metal-poor Galaxies

Entrectinib‐induced syndrome of inappropriate antidiuretic hormone secretion in a patient with ROS1 ‐rearranged non‐small cell lung cancer

Suchergebnisse filtern